O'Byrne Jason (CIK 1871145) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-23). Recent activity: Sell VIR (2,500 shares), Buy VIR (2,500 shares), Sell VIR (1,634 shares), Buy VIR (55,000 shares), Sell VIR (2,089 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-23 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Sell | 2,500 | $0 |
| 2026-03-23 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Buy | 2,500 | $0 |
| 2026-02-26 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Sell | 1,634 | $15,572 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Buy | 55,000 | $0 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Sell | 2,089 | $15,563 |
| 2025-11-18 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Sell | 6,799 | $37,802 |
| 2025-02-25 | Vir Biotechnology, Inc. (VIR) | EVP & Chief Financial Officer | Buy | 40,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-23